Cargando…

Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology

The incidence of pulmonary and venous thromboembolism is increased during the first trimester of pregnancies after assisted reproductive technology (ART) compared to spontaneous conception. We previously found that haemostatic plasma variables changed but within normal limits during controlled ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Olausson, Nina, Mobarrez, Fariborz, Zubarev, Roman, Chernobrovkin, Alexey, Rutishauser, Dorothea, Bremme, Katarina, Westerlund, Eli, Hovatta, Outi, Wallén, Håkan, Henriksson, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423945/
https://www.ncbi.nlm.nih.gov/pubmed/32788624
http://dx.doi.org/10.1038/s41598-020-70541-w
_version_ 1783570231266902016
author Olausson, Nina
Mobarrez, Fariborz
Zubarev, Roman
Chernobrovkin, Alexey
Rutishauser, Dorothea
Bremme, Katarina
Westerlund, Eli
Hovatta, Outi
Wallén, Håkan
Henriksson, Peter
author_facet Olausson, Nina
Mobarrez, Fariborz
Zubarev, Roman
Chernobrovkin, Alexey
Rutishauser, Dorothea
Bremme, Katarina
Westerlund, Eli
Hovatta, Outi
Wallén, Håkan
Henriksson, Peter
author_sort Olausson, Nina
collection PubMed
description The incidence of pulmonary and venous thromboembolism is increased during the first trimester of pregnancies after assisted reproductive technology (ART) compared to spontaneous conception. We previously found that haemostatic plasma variables changed but within normal limits during controlled ovarian hyperstimulation (COH) concomitant with a major increase in plasma microvesicles (MVs) and markers indicating cell activation. We now explored the proteome of these MVs. Thirty-one women undergoing ART were blood sampled at down-regulation (DR) of oestrogen and at high level stimulation (HLS) with its 10–100-fold increased oestrogen level. Samples were analysed by liquid chromatography and tandem mass spectrometry to identify and quantify the proteome. We identified 306 proteins in the MVs and 72 had changed significantly at HLS compared to DR and more than 20% of them were associated with haemostasis. Thus, proteins related to both haemostasis and complement activation altered in plasma MVs in parallel with MV activation during COH. This needs to be further explored in the clinical context.
format Online
Article
Text
id pubmed-7423945
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74239452020-08-14 Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology Olausson, Nina Mobarrez, Fariborz Zubarev, Roman Chernobrovkin, Alexey Rutishauser, Dorothea Bremme, Katarina Westerlund, Eli Hovatta, Outi Wallén, Håkan Henriksson, Peter Sci Rep Article The incidence of pulmonary and venous thromboembolism is increased during the first trimester of pregnancies after assisted reproductive technology (ART) compared to spontaneous conception. We previously found that haemostatic plasma variables changed but within normal limits during controlled ovarian hyperstimulation (COH) concomitant with a major increase in plasma microvesicles (MVs) and markers indicating cell activation. We now explored the proteome of these MVs. Thirty-one women undergoing ART were blood sampled at down-regulation (DR) of oestrogen and at high level stimulation (HLS) with its 10–100-fold increased oestrogen level. Samples were analysed by liquid chromatography and tandem mass spectrometry to identify and quantify the proteome. We identified 306 proteins in the MVs and 72 had changed significantly at HLS compared to DR and more than 20% of them were associated with haemostasis. Thus, proteins related to both haemostasis and complement activation altered in plasma MVs in parallel with MV activation during COH. This needs to be further explored in the clinical context. Nature Publishing Group UK 2020-08-12 /pmc/articles/PMC7423945/ /pubmed/32788624 http://dx.doi.org/10.1038/s41598-020-70541-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Olausson, Nina
Mobarrez, Fariborz
Zubarev, Roman
Chernobrovkin, Alexey
Rutishauser, Dorothea
Bremme, Katarina
Westerlund, Eli
Hovatta, Outi
Wallén, Håkan
Henriksson, Peter
Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title_full Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title_fullStr Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title_full_unstemmed Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title_short Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
title_sort changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423945/
https://www.ncbi.nlm.nih.gov/pubmed/32788624
http://dx.doi.org/10.1038/s41598-020-70541-w
work_keys_str_mv AT olaussonnina changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT mobarrezfariborz changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT zubarevroman changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT chernobrovkinalexey changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT rutishauserdorothea changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT bremmekatarina changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT westerlundeli changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT hovattaouti changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT wallenhakan changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology
AT henrikssonpeter changesintheplasmamicrovesicleproteomeduringtheovarianhyperstimulationphaseofassistedreproductivetechnology